The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Genome Canada

Monday Biotech Deal Review: March 29, 2011

Welcome to your Monday Biotech Deal Review for March 28, 2011.  There was a flurry of financing activity last week, with over $76M raised or announced in biotech funds (not including the $60M Genome Canada investment announced by the Government of Canada).  Double-digit million-dollar deals included MethylGene’s $34.5M private placement announcement, Medicago’s $17M private placement [...]

Monday Biotech Deal Review: July 26, 2010

Things were interesting for Forbes Medi-Tech (or at least its creditors), which saw a new bidder emerge for its assets. A few placements and other deals closed, some lower than expected. See who made it through the heat without wilting this week

More Highlights in Canada’s 2010 Federal Budget For Biotech, Venture Capital and Innovation Groups

My first take on the most important bits for Canadian biotech companies and investors: 1) Looks like Section 116 will stay dead this time! 2) Better for research funding, with Genome Canada, NSERC, CIHR, SSHRC coming out much better than last year.  Grease?  Meet squeaky wheel. 3) Is this the end of the SIFT/SR&ED deals?  [...]

I’ll Drink To That: Genome BC and Genome Canada Launch $3.4 million Grape and Wine Genomics Project

A team of researchers in British Columbia (UBC, SFU), Ontario (Guelph) and elsewhere (NRC, USDA) will be studying grapes and yeast to bring molecular techniques to bear on winemaking.  Ultimately, they aim to produce a hand-held device to “help growers monitor proteins in the vine or berry at any time” (a “vine-corder”?) that will be [...]

It’s a Bird! It’s a Plane! It’s Super Provincial Genomics Funding!!

You may remember Genome Canada’s reaction to the 2009 Canadian Federal budget.  Here’s one bit from ScienceInsider at the time: Researchers funded by Genome Canada … are reacting with shock to news that the Canadian government is withdrawing funding from the 9-year-old organization. Not true! Cried the Canadian government. Well, this week Genome Canada’s Board [...]

Essex Woodland Health Ventures’ New $900 million Bio Fund

Essex Woodlands Health Ventures closed on its Fund VIII today with $900 million to invest “across the spectrum of drug, device and service companies in North America, Europe and Asia.”  The In Vivo blog points out that this isn’t exactly new news, but it is still good news for companies that are now a big step [...]

The Face of Cod

The government has given a $3 million grant to Genome Atlantic to conduct genomic studies of atlantic cod.  This is the first part of a 4-year, $5.8 million project.  According to The New Brunswick Business Journal: Early maturation results in a slower growth rate for the fish. That means a longer wait before harvesting, and [...]

Friday Science Review: February 6, 2009

Canada’s Budget: An Innovation Shortfall

A good piece by David Crane in the Toronto Star today that touches on the BIOTECanada and Genome Canada issues, as well as a broader indictment: There are some initiatives in the budget that will help. But overall it falls far short of what is required for an innovative economy, one that will deliver the [...]

Follow

Get every new post delivered to your Inbox.

Join 84 other followers